Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.theravance.com/investor-relations
Company Research
Source: Yahoo! Finance
Collaboration Revenue: $16.9 million, an 8% increase compared to last year. Hospital Doses: 227,000 doses shipped, a 40% increase compared to Q3 2023. Cash Position: $91 million at the end of the period. Operating Expenses: G&A expenses decreased by 7% in the quarter and 21% year-to-date. Share-Based Compensation: $5 million for the quarter, a 21% reduction compared to last year. Non-Cash Impairment Charge: $1.6 million due to the write-down of operating lease assets. Shares Outstanding: 49 million shares. Warning! GuruFocus has detected 3 Warning Signs with TBPH. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Theravance Biopharma Inc ( NASDAQ:TBPH ) reported a 7% year-over-year growth in net sales, reaching an all-time high of $62.2 million. The company made solid progress on its pivotal Cypress study for Ampel Oxetin, remaining on target to achieve updated timelines. GSK del
Show less
Read more
Impact Snapshot
Event Time:
TBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TBPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TBPH alerts
High impacting Theravance Biopharma, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TBPH
News
- KBR Stock Soars 5%: Activist Investor Pushes for Breakup to Unlock 50% Value Surge [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferencePR Newswire
- The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Participate in an Upcoming Investor ConferencePR Newswire
- Kevin Krause named President and CEO of ArrePath [Yahoo! Finance]Yahoo! Finance
TBPH
Earnings
- 11/12/24 - Miss
TBPH
Sec Filings
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- TBPH's page on the SEC website